PTEN and breast cancer: Otherwise, clinical data showed that the activation of Akt or reduction of PTEN, a tumor suppressor mediating dephosphorylation of PIP3 to PIP2, were associated with tamoxifen resistance in both metastatic and recurrent breast cancer patients63,64.